Session information
- Title:
- Focus on CAR T cell therapy
- Description:
- This session provides an overview for healthcare professionals of Chimeric Antigen Receptor (CAR) T cell therapy products covering how they are made, the mechanism of action and the clinical pathway from apheresis to clinical delivery and patient management. The benefits and side-effects of the therapy will be discussed in the context of currently available commercial CAR T products
- Hierarchy:
- Advanced Therapy Medicinal Products (ATMP) > Advanced Therapy Medicinal Products > Focus on CAR T cell therapy
- Created:
- 8 Jul 2021
- Last Major Update:
- 8 Jul 2021
- Keywords:
- 830-0002, advanced, therapies, medicinal, product, ATMP, CAR T, chimeric, antigen, receptor, gene therapy, ex vivo, CRS, ICANS, autologous, T cell
- Quicklink:
- 830-0002
Share this item
- Copy URL
Overall rating
4.5/5
4.5/5
Content
4.6/5
4.6/5
Presentation
4.6/5
4.6/5
Interactivity
4.5/5
4.5/5
Self assessments
4.5/5
4.5/5
Overall rating
4.5/5
4.5/5
Content
4.6/5
4.6/5
Presentation
4.6/5
4.6/5
Interactivity
4.5/5
4.5/5
Self assessments
4.5/5
4.5/5
- Title:
- Focus on CAR T cell therapy
- Description:
- This session provides an overview for healthcare professionals of Chimeric Antigen Receptor (CAR) T cell therapy products covering how they are made, the mechanism of action and the clinical pathway from apheresis to clinical delivery and patient management. The benefits and side-effects of the therapy will be discussed in the context of currently available commercial CAR T products
- Hierarchy:
- Advanced Therapy Medicinal Products (ATMP) > Advanced Therapy Medicinal Products > Focus on CAR T cell therapy
- Created:
- 8 Jul 2021
- Last Major Update:
- 8 Jul 2021
- Keywords:
- 830-0002, advanced, therapies, medicinal, product, ATMP, CAR T, chimeric, antigen, receptor, gene therapy, ex vivo, CRS, ICANS, autologous, T cell
- Quicklink:
- 830-0002